Compare Direxion Daily CSI China Internet Bull 2X Shares (CWEB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily CSI China Internet Bull 2X Shares vs State Street SPDR S&P Biotech ETF — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.91 (market cap $173.62M), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 58.2× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Direxion Daily CSI China Internet Bull 2X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| CWEB | XBI | |
|---|---|---|
Market Cap | $173.62M | $10.11B |
Volume | 551,726 | 12,903,266 |
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $54.91 | $169.55 |
52-Week Low | $17.39 | $104.99 |
Typical Hold Time | 24 Days | 38 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CWEB is trading at $17.57, down 2.5% today amid bearish technical signals. The stock shows weak momentum with 18 sell signals versus just 1 buy signal across technical indicators. Recent news highlights China's AI ambitions and potential for China growth stocks to surge, providing thematic tailwinds despite current technical weakness.
The outlook remains cautious with technical indicators pointing to continued pressure, though exposure to China's AI development offers long-term growth potential. Key risks include China market volatility and regulatory uncertainties, while the absence of fundamental data requires careful monitoring of upcoming financial disclosures.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Direxion Daily CSI China Internet Bull 2X Shares
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
